DYRK1A inhibitors (UFR Sciences Pharmaceuticals/Centre National de la Recherche Scientifique (CNRS)/Universite De Rennes 1/INSERM/ManRos Therapeutics/Universite de Nantes)

N/A

Report date: 2025/01/26 18:47:02
NME

Base Information

Drug NameDYRK1A inhibitors (UFR Sciences Pharmaceuticals/Centre National de la Recherche Scientifique (CNRS)/Universite De Rennes 1/INSERM/ManRos Therapeutics/Universite de Nantes)
Drug Alias NameL-41
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDual-specificity tyrosine-phosphorylation regulated kinase 1A inhibitors
TargetsDual-specificity tyrosine-phosphorylation regulated kinase 1A
Therapy Area/IndicationsDown Syndrome
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFrance
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUFR Sciences Pharmaceuticals
China Registration ClassN/A

Develop Information

Active CompaniesRennes 1 UniversityInstitut National De La Sante Et De La Recherche MedicaleUFR Sciences Pharmaceuticals +[6] 
Inactive CompaniesN/A
Active IndicationsDown Syndrome
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A